Varex Imaging Corp VREX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VREX is a good fit for your portfolio.
News
-
Varex Announces Financial Results for Second Quarter Fiscal Year 2024
-
Varex Schedules Second Quarter Fiscal Year 2024 Earnings Release and Conference Call
-
Varex Announces Closing of Revolving Credit Facility of $155 Million
-
Varex to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Virtual Conference
Trading Information
- Previous Close Price
- $15.89
- Day Range
- $14.92–15.83
- 52-Week Range
- $14.56–23.90
- Bid/Ask
- $15.23 / $22.00
- Market Cap
- $627.55 Mil
- Volume/Avg
- 468,485 / 343,921
Key Statistics
- Price/Earnings (Normalized)
- 15.28
- Price/Sales
- 0.94
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,300
- Website
- https://www.vareximaging.com
Comparables
Valuation
Metric
|
VREX
|
688607
|
GBT
|
---|---|---|---|
Price/Earnings (Normalized) | 15.28 | 39.54 | 21.00 |
Price/Book Value | 1.13 | 1.40 | 1.23 |
Price/Sales | 0.94 | 4.51 | 0.59 |
Price/Cash Flow | 11.14 | 35.07 | 5.73 |
Price/Earnings
VREX
688607
GBT
Financial Strength
Metric
|
VREX
|
688607
|
GBT
|
---|---|---|---|
Quick Ratio | 2.21 | 8.48 | 1.06 |
Current Ratio | 4.23 | 9.73 | 2.54 |
Interest Coverage | 1.51 | 28.27 | 3.89 |
Quick Ratio
VREX
688607
GBT
Profitability
Metric
|
VREX
|
688607
|
GBT
|
---|---|---|---|
Return on Assets (Normalized) | 3.14% | 0.11% | 2.26% |
Return on Equity (Normalized) | 6.99% | 0.11% | 5.91% |
Return on Invested Capital (Normalized) | 5.28% | 0.03% | 4.06% |
Return on Assets
VREX
688607
GBT
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vhrrlcq | Mjsmtdz | $182.6 Bil | |
SYK
| Stryker Corp | Vdykhwzvm | Ddzdv | $125.9 Bil | |
MDT
| Medtronic PLC | Cqgwnhdz | Pwvfkn | $108.3 Bil | |
BSX
| Boston Scientific Corp | Vgycqdg | Dgqnwv | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Mcccyzyqvj | Ppbdw | $52.3 Bil | |
DXCM
| DexCom Inc | Zsnjcmhtvs | Pgjr | $50.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Hbfqnpwjs | Wdqk | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Hntxvmtf | Yvxfy | $24.3 Bil | |
ALGN
| Align Technology Inc | Cqnxfclgg | Pqtkzw | $21.1 Bil | |
PODD
| Insulet Corp | Hvgxqlszkq | Zqnvm | $12.4 Bil |